Search

Your search keyword '"Sopova K"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Sopova K" Remove constraint Author: "Sopova K"
72 results on '"Sopova K"'

Search Results

2. Plasma levels of amyloid beta 1-40 are associated with ultrasonographic morphological characteristics related with carotid plaque vulnerability in individuals without cardiovascular disease

3. Circulating amyloid-beta 1-40 levels associate with cardiac remodelling and myocardial recovery in advanced heart failure

5. RNA-binding protein HuR controls vascular endothelial cell inflammatory responses to tumor necrosis factor-A and is associated with atherosclerosis progression in humans

9. Clinical frailty, and not features of acute infection, is associated with late mortality in COVID-19: a retrospective cohort study

10. Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19

13. Prognostic and reclassification value of serum cathepsin S over the GRACE risk score in patients with non-ST-segment elevation acute coronary syndrome

14. Amyloid- (1-40) and Mortality in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome A Cohort Study

15. 265Amyloid beta 1-40 and its upstream regulatory pathway BACE1-AS long noncoding RNA/BACE1 are associated with presence and severity of human atherosclerotic disease

16. P2541Plasma levels of amyloid beta 1-40 are associated with the rate of progression of carotid subclinical atherosclerosis in postmenopausal women

17. 2228Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom

18. P4492Peripheral blood mononuclear cell expression of the stabilizing RNA-binding protein HuR is associated with incidence and extent of human atherosclerotic cardiovascular disease

19. P1732The additive value of pre- and post-reperfusion cardiac troponin T levels in risk stratification of patients with ST-segment elevation myocardial infarction

21. The Russian Frontier in Western Siberia (XVI–XVIII centuries) — an archaeological rendition

22. Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease

23. Increased myeloperoxidase plasma levels in patients with alzheimer's disease

24. Expression of platelet-bound stromal cell-derived factor-1 in patients with non-valvular atrial fibrillation and ischemic heart disease

25. Plasma levels of stromal cell-derived factor-1 in patients with coronary artery disease: Effect of clinical presentation and cardiovascular risk factors

30. Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.

31. Amyloid-beta metabolism in age-related neurocardiovascular diseases.

32. Incremental value of blood-based markers of liver fibrosis in cardiovascular risk stratification.

33. Amyloid beta is associated with carotid wall echolucency and atherosclerotic plaque composition.

34. Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes.

35. Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction.

36. Beta-Secretase-1 Antisense RNA Is Associated with Vascular Ageing and Atherosclerotic Cardiovascular Disease.

37. Cathepsin S Levels and Survival Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

38. Clinical frailty, and not features of acute infection, is associated with late mortality in COVID-19: a retrospective cohort study.

39. Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.

40. Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19.

41. Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State.

42. The Fractalkine Receptor CX 3 CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling.

43. Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease.

44. Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis.

45. Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.

46. Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.

47. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.

48. Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.

49. Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer's disease: from pathophysiology to novel treatment strategies.

50. Platelets as potential link between diabetes and Alzheimer's disease.

Catalog

Books, media, physical & digital resources